Issues in patient cohort, surrogate outcome measures and conflicts of interest of JAMA Neurology's Dhruva et al. propensity-matched retrospective evaluation of a single insurer administrative claims data of spinal cord stimulation compared with conventional medical therapy for chronic pain

Sam Eldabe¹, Christopher Gilligan², Rod S Taylor³, Kiran V Patel^{4

5}, Rui V Duarte^{6

7}

Affiliations

¹ Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
² Division of Pain Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts, USA.
³ MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, Glasgow, UK.
⁴ The Spine & Pain Institute of New York, New York, New York, USA.
⁵ Department of Anesthesiology, NYU Langone Medical Center, New York, New York, USA.
⁶ Saluda Medical Pty Ltd., Artarmon, New South Wales, Australia.
⁷ Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK.

Editorial

Sam Eldabe et al. Pain Pract. 2023 Jun.

. 2023 Jun;23(5):475-478.

doi: 10.1111/papr.13213.

Sam Eldabe¹, Christopher Gilligan², Rod S Taylor³, Kiran V Patel^{4

5}, Rui V Duarte^{6

7}

¹ Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.
² Division of Pain Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts, USA.
³ MRC/CSO Social and Public Health Sciences Unit & Robertson Centre for Biostatistics, Institute of Health and Well Being, University of Glasgow, Glasgow, UK.
⁴ The Spine & Pain Institute of New York, New York, New York, USA.
⁵ Department of Anesthesiology, NYU Langone Medical Center, New York, New York, USA.
⁶ Saluda Medical Pty Ltd., Artarmon, New South Wales, Australia.
⁷ Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK.

No abstract available

Comment on

Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain.
Dhruva SS, Murillo J, Ameli O, Morin PE, Spencer DL, Redberg RF, Cohen K. Dhruva SS, et al. JAMA Neurol. 2023 Jan 1;80(1):18-29. doi: 10.1001/jamaneurol.2022.4166. JAMA Neurol. 2023. PMID: 36441532 Free PMC article.

1. Dhruva SS, Murillo J, Ameli O, Morin PE, Spencer DL, Redberg RF, et al. Long-term outcomes in use of opioids, nonpharmacologic pain interventions, and total costs of spinal cord stimulators compared with conventional medical therapy for chronic pain. JAMA Neurol. 2022;80:18.
1. Shirvalkar P, Poree L. How SAFE is real-world use of spinal cord stimulation therapy for chronic pain? JAMA Neurol. 2023;80(1):10-11.
1. National Institute for Health and Care Excellence. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin. Technology appraisal guidance [TA159] 2008.
1. Kapural L, Yu C, Doust MW, Gliner BE, Vallejo R, Sitzman BT, et al. Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic Back and leg pain: the SENZA-RCT randomized controlled trial. Anesthesiology. 2015;123:851-60.
1. Mekhail N, Levy RM, Deer TR, Kapural L, Li S, Amirdelfan K, et al. Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trial. Lancet Neurol. 2020;19:123-34.